Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
AMEXUtilitiesOil & Gas Exploration & ProductionSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for AGIG yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Complete acquisition of RPD Technologies | Abundia completed the acquisition of RPD Technologies to grow its market. | Intact | Acquisition not completed or integration fails by FY26 end | Acquisition completed Apr 1, 2026 vs FY26 target Material Definitive Agreement filed April 2026 confirms acquisition of all RPD membership interests. Nov 4, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 18, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earningsObserved price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a speculative growth business, not a proven durable compounder, because it remains loss-making and its financial performance is weak. The thesis is in a watch state, with volatile management execution and high overall risk.
The valuation model indicates AGIG is expensive versus peers, while the expectations gap is driven by optionality, or the possibility that future growth initiatives create value. Model confidence is low, and the evidence does not show that current losses justify the valuation.
Near term, ongoing losses and negative operating income leave financial performance weak. The company completed the RPD Technologies acquisition and secured a shareholder credit facility to repay convertible debt and support commercialization, but the impact remains uncertain. The newly authorized buyback adds a capital allocation commitment amid those losses.
Over the next 1 to 3 years, the thesis hinges on whether commercialization and the RPD acquisition translate into stronger financial performance. Near-term sector signals include interest-rate changes and earnings from utility bellwethers, though the evidence for how these factors affect AGIG specifically is limited.
AGIG’s multi-year view is uncertain: growth initiatives offer potential, but losses, weak performance, and execution risk remain central. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| Capital allocation is being managed despite challenges. |
| Under Pressure |
| Additional dilutive equity sales or unsustainable debt increase in FY26 |
Debt +$6.5M vs manageable target Company issued $6.5M secured note with up to $10M total capacity, alongside a $5M share repurchase authorization. Nov 4, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Address financial statement reliability | The company is working to fix financial statement issues. | Intact | Financial statement issues remain unresolved past FY26 | Qualitative condition This condition has no defined numerical measure. Nov 4, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$-0.17 → $-0.34 · observed estimates
$0.00B → $0.01B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $-0.17 | $255,474 | 1 / 1 |
| 2026-07-25 | $-0.17 | $255,474 | 1 / 1 |
| 2026-07-26 | $-0.17 | $255,474 | 1 / 1 |
| 2026-07-27 | $-0.17 | $255,474 | 1 / 1 |
| 2026-07-28 | $-0.17 | $255,474 | 1 / 1 |
| 2026-07-29 | $-0.17 | $255,474 | 1 / 1 |
| 2026-07-30 | $-0.17 | $0 | 1 / 1 |
| 2026-07-31 | $-0.17 | $0 | 1 / 1 |
| 2026-08-01 | $-0.17 | $0 | 1 / 1 |
| 2026-08-02 | $-0.17 | $0 | 1 / 1 |
| 2026-08-03 | $-0.17 | $0 | 1 / 1 |
| 2026-08-04 | $-0.17 | $0 | 1 / 1 |
| 2026-08-05 | $-0.17 | $0 | 1 / 1 |
| 2026-08-06 | $-0.17 | $0 | 1 / 1 |
| 2026-08-07 | $-0.17 | $0 | 1 / 1 |
| 2026-08-08 | $-0.17 | $0 | 1 / 1 |
| 2026-08-09 | $-0.17 | $0 | 1 / 1 |
| 2026-08-10 | $-0.17 | $0 | 1 / 1 |
| 2026-08-11 | $-0.17 | $0 | 1 / 1 |
| 2026-08-12 | $-0.17 | $0 | 1 / 1 |
| 2026-08-13 | $-0.17 | $0 | 1 / 1 |
| 2026-08-14 | $-0.17 | $255,474 | 1 / 1 |
| 2026-08-15 | $-0.17 | $255,474 | 1 / 1 |
| 2026-08-16 | $-0.17 | $255,474 | 1 / 1 |
| 2026-08-17 | $-0.17 | $255,474 | 1 / 1 |
| 2026-08-18 | $-0.17 | $255,474 | 1 / 1 |
| 2026-08-19 | $-0.17 | $255,474 | 1 / 1 |
| 2026-08-20 | $-0.17 | $255,474 | 1 / 1 |
| 2026-08-21 | $-0.17 | $255,474 | 1 / 1 |
| 2026-08-22 | $-0.17 | $255,474 | 1 / 1 |
| 2026-08-23 | $-0.17 | $255,474 | 1 / 1 |
| 2026-08-24 | $-0.17 | $255,474 | 1 / 1 |
| 2026-08-25 | $-0.17 | $255,474 | 1 / 1 |
| 2026-08-26 | $-0.17 | $255,474 | 1 / 1 |
| 2026-08-27 | $-0.17 | $255,474 | 1 / 1 |
| 2026-08-28 | $-0.17 | $255,474 | 1 / 1 |
| 2026-08-29 | $-0.17 | $255,474 | 1 / 1 |
| 2026-08-30 | $-0.17 | $255,474 | 1 / 1 |
| 2026-08-31 | $-0.17 | $255,474 | 1 / 1 |
| 2026-09-01 | $-0.17 | $255,474 | 1 / 1 |
| 2026-09-02 | $-0.17 | $255,474 | 1 / 1 |
| 2026-09-03 | $-0.17 | $255,474 | 1 / 1 |
| 2026-09-04 | $-0.17 | $255,474 | 1 / 1 |
| 2026-09-05 | $-0.17 | $255,474 | 1 / 1 |
| 2026-09-06 | $-0.17 | $255,474 | 1 / 1 |
| 2026-09-07 | $-0.17 | $255,474 | 1 / 1 |
| 2026-09-08 | $-0.17 | $255,474 | 1 / 1 |
| 2026-09-09 | $-0.17 | $255,474 | 1 / 1 |
| 2026-09-10 | $-0.17 | $255,474 | 1 / 1 |
| 2026-09-11 | $-0.17 | $255,474 | 1 / 1 |
| 2026-09-12 | $-0.17 | $255,474 | 1 / 1 |
| 2026-09-13 | $-0.17 | $255,474 | 1 / 1 |
| 2026-09-14 | $-0.17 | $255,474 | 1 / 1 |
| 2026-09-15 | $-0.17 | $255,474 | 1 / 1 |
| 2026-09-16 | $-0.17 | $255,474 | 1 / 1 |
| 2026-09-17 | $-0.17 | $255,474 | 1 / 1 |
| 2026-09-18 | $-0.17 | $255,474 | 1 / 1 |
| 2026-09-19 | $-0.17 | $255,474 | 1 / 1 |
| 2026-09-20 | $-0.21 | $10,000,000 | 1 / 1 |
| 2026-09-21 | $-0.21 | $10,000,000 | 1 / 1 |
| 2026-09-22 | $-0.21 | $10,000,000 | 1 / 1 |
| 2026-09-23 | $-0.21 | $10,000,000 | 1 / 1 |
| 2026-09-24 | $-0.21 | $10,000,000 | 1 / 1 |
| 2026-09-25 | $-0.21 | $10,000,000 | 1 / 1 |
| 2026-09-26 | $-0.21 | $10,000,000 | 1 / 1 |
| 2026-09-27 | $-0.21 | $10,000,000 | 1 / 1 |
| 2026-09-28 | $-0.21 | $10,000,000 | 1 / 1 |
| 2026-09-29 | $-0.21 | $10,000,000 | 1 / 1 |
| 2026-09-30 | $-0.21 | $10,000,000 | 1 / 1 |
| 2026-10-01 | $-0.21 | $10,000,000 | 1 / 1 |
| 2026-10-02 | $-0.21 | $10,000,000 | 1 / 1 |
| 2026-10-03 | $-0.21 | $10,000,000 | 1 / 1 |
| 2026-10-04 | $-0.21 | $10,000,000 | 1 / 1 |
| 2026-10-05 | $-0.21 | $10,000,000 | 1 / 1 |
| 2026-10-06 | $-0.21 | $10,000,000 | 1 / 1 |
| 2026-10-07 | $-0.21 | $10,000,000 | 1 / 1 |
| 2026-10-08 | $-0.21 | $10,000,000 | 1 / 1 |
| 2026-10-09 | $-0.21 | $10,000,000 | 1 / 1 |
| 2026-10-10 | $-0.21 | $10,000,000 | 1 / 1 |
| 2026-10-11 | $-0.21 | $10,000,000 | 1 / 1 |
| 2026-10-12 | $-0.21 | $10,000,000 | 1 / 1 |
| 2026-10-13 | $-0.21 | $10,000,000 | 1 / 1 |
| 2026-10-14 | $-0.21 | $10,000,000 | 1 / 1 |
| 2026-10-15 | $-0.21 | $10,000,000 | 1 / 1 |
| 2026-10-16 | $-0.21 | $10,000,000 | 1 / 1 |
| 2026-10-17 | $-0.21 | $10,000,000 | 1 / 1 |
| 2026-10-18 | $-0.21 | $10,000,000 | 1 / 1 |
| 2026-10-19 | $-0.21 | $10,000,000 | 1 / 1 |
| 2026-10-20 | $-0.21 | $10,000,000 | 1 / 1 |
| 2026-10-21 | $-0.21 | $10,000,000 | 1 / 1 |
| 2026-10-22 | $-0.21 | $10,000,000 | 1 / 1 |
| 2026-10-23 | $-0.21 | $10,000,000 | 1 / 1 |
| 2026-10-24 | $-0.34 | $7,350,000 | 1 / 1 |
| 2026-10-25 | $-0.34 | $7,350,000 | 1 / 2 |
| 2026-10-26 | $-0.34 | $7,350,000 | 1 / 2 |
| 2026-10-27 | $-0.34 | $7,350,000 | 1 / 2 |
| 2026-10-28 | $-0.34 | $7,350,000 | 1 / 1 |
| 2026-10-29 | $-0.34 | $7,350,000 | 1 / 1 |
| 2026-10-30 | $-0.34 | $7,350,000 | 1 / 1 |
| 2026-10-31 | $-0.34 | $7,350,000 | 1 / 1 |
| 2026-11-01 | $-0.34 | $7,350,000 | 1 / 1 |
| 2026-11-02 | $-0.34 | $7,350,000 | 1 / 1 |
| 2026-11-03 | $-0.34 | $7,350,000 | 1 / 1 |
| 2026-11-04 | $-0.34 | $7,350,000 | 1 / 1 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 2 Buy / Strong Buy · 0 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 0 recorded
0 raises · 0 cuts · 0 unchanged · 1 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
2 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.